JHS Svendgaard Laboratories Ltd
Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]
- Market Cap ₹ 68.5 Cr.
- Current Price ₹ 7.86
- High / Low ₹ 13.9 / 6.15
- Stock P/E
- Book Value ₹ 20.0
- Dividend Yield 0.00 %
- ROCE -0.78 %
- ROE -1.11 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.39 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.18% over past five years.
- Promoter holding is low: 33.8%
- Company has a low return on equity of -4.75% over last 3 years.
- Earnings include an other income of Rs.2.55 Cr.
- Promoter holding has decreased over last 3 years: -8.38%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55 | 100 | 104 | 140 | 124 | 139 | 101 | 86 | 85 | 71 | 92 | 102 | 109 | |
| 59 | 93 | 92 | 126 | 124 | 137 | 99 | 87 | 94 | 72 | 96 | 99 | 106 | |
| Operating Profit | -4 | 7 | 12 | 14 | 0 | 2 | 2 | -1 | -9 | -1 | -4 | 3 | 3 |
| OPM % | -7% | 7% | 11% | 10% | 0.1% | 1.2% | 1.9% | -1.0% | -11% | -1.3% | -4.4% | 2.6% | 2.8% |
| -6 | -17 | 0 | 32 | 6 | 3 | 7 | 9 | -7 | 4 | 0 | 3 | 3 | |
| Interest | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 12 | 10 | 6 | 7 | 7 | 9 | 7 | 7 | 6 | 6 | 8 | 8 | 7 |
| Profit before tax | -22 | -22 | 5 | 38 | -2 | -6 | 1 | 0 | -23 | -3 | -13 | -2 | -3 |
| Tax % | 0% | 0% | -327% | 32% | -19% | -17% | -39% | 4,000% | -24% | 18% | 58% | -16% | |
| -22 | -22 | 22 | 26 | -2 | -5 | 1 | -4 | -18 | -4 | -20 | -2 | -2 | |
| EPS in Rs | -9.20 | -5.76 | 4.98 | 4.29 | -0.11 | -0.33 | 0.19 | -0.62 | 0.62 | -0.52 | -2.31 | -0.22 | -0.22 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 6% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -21% |
| 3 Years: | -31% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | -5% |
| Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 38 | 44 | 61 | 61 | 61 | 64 | 65 | 78 | 78 | 86 | 87 |
| Reserves | 96 | 63 | 90 | 113 | 116 | 117 | 124 | 121 | 95 | 91 | 87 | 87 |
| 19 | 3 | 2 | 2 | 7 | 9 | 7 | 6 | 3 | 5 | 6 | 15 | |
| 33 | 19 | 19 | 32 | 39 | 55 | 33 | 30 | 52 | 22 | 25 | 26 | |
| Total Liabilities | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 228 | 197 | 204 | 215 |
| 108 | 65 | 65 | 71 | 71 | 66 | 63 | 59 | 65 | 90 | 90 | 89 | |
| CWIP | 0 | 1 | 1 | 1 | 5 | 7 | 9 | 20 | 9 | 1 | 0 | 4 |
| Investments | 0 | 0 | 1 | 18 | 10 | 6 | 2 | 4 | 3 | 3 | 4 | 5 |
| 63 | 57 | 89 | 118 | 137 | 163 | 154 | 140 | 152 | 102 | 110 | 117 | |
| Total Assets | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 228 | 197 | 204 | 215 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | -4 | -4 | 14 | -11 | 10 | 12 | -9 | 23 | -9 | -5 | -3 | |
| 1 | 1 | -3 | -27 | -7 | -11 | -2 | -5 | 10 | -21 | -20 | -12 | |
| -10 | 4 | 10 | 14 | 13 | 0 | 10 | -2 | -1 | 2 | 23 | 11 | |
| Net Cash Flow | -1 | 2 | 3 | 0 | -5 | -0 | 20 | -16 | 32 | -28 | -2 | -3 |
| Free Cash Flow | 9 | -7 | -17 | 3 | -26 | 0 | 5 | -16 | 21 | -33 | -14 | -15 |
| CFO/OP | -189% | -58% | -33% | 119% | -10,000% | 595% | 650% | 1,051% | -257% | 1,001% | 122% | -77% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 167 | 25 | 48 | 111 | 158 | 252 | 213 | 77 | 80 | 66 | 52 | 60 |
| Inventory Days | 94 | 53 | 95 | 65 | 60 | 30 | 97 | 114 | 128 | 176 | 153 | 85 |
| Days Payable | 106 | 67 | 123 | 153 | 134 | 177 | 128 | 130 | 197 | 197 | 141 | 100 |
| Cash Conversion Cycle | 156 | 12 | 19 | 23 | 85 | 105 | 182 | 61 | 11 | 46 | 63 | 45 |
| Working Capital Days | -39 | 58 | 56 | 122 | 173 | 198 | 272 | 217 | 41 | 51 | 48 | 42 |
| ROCE % | -12% | -3% | 5% | 8% | -0% | 4% | 1% | 1% | -2% | -2% | -5% | -1% |
Insights
In beta| Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Export revenue share % of revenue |
|
|||||||
| Toothbrush revenue share % of revenue |
||||||||
| Toothpaste revenue share % of revenue |
||||||||
| Number of permanent employees count ・Standalone data |
||||||||
| Talcum and other new categories revenue share % of revenue |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication regarding dispatch of 22nd AGM Notice
-
Notice Of 22Nd Annual General Meeting
- 22nd AGM on September 26, 2026 at 3:00 PM via VC/OAVM; Paramvir Singh seeks reappointment.
-
Reg. 34 (1) Annual Report.
- Integrated Annual Report FY2025-26 and notice for 22nd AGM uploaded.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- JHS Svendgaard Laboratories Limited has informed about the publication of Newspaper Advertisement regarding the details of Annual General Meeting.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication of Un- Audited Financial Results for the Quarter Ended June 30, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets